Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityNo recent work listed

Hongyu Wu

Matched on ORCID iD 0000-0001-7503-2734; OpenAlex author ID A5100341974. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 3 papers · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper

Papers 7

  1. Triptolide enhances the sensitivity of pancreatic cancer PANC-1 cells to gemcitabine by inhibiting TLR4/NF-κB signaling. Co-author PMID 31312385↗
  2. Proteasome activator subunit 3 promotes pancreatic cancer growth via c-Myc-glycolysis signaling axis. Co-author DOI 10.1016/j.canlet.2016.08.018↗
  3. Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCs. Co-author DOI 10.1080/15384101.2015.1127471↗
  4. Adenovirus vector-mediated Gli1 siRNA induces growth inhibition and apoptosis in human pancreatic cancer with Smo-dependent or Smo-independent Hh pathway activ… Last author DOI 10.1016/j.canlet.2013.06.010↗
  5. Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression. Co-author DOI 10.1186/1756-9966-32-86↗
  6. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF. Co-author DOI 10.3727/096504013x13657689382932↗
  7. Continuous and low-energy 125I seed irradiation changes DNA methyltransferases expression patterns and inhibits pancreatic cancer tumor growth. Co-author DOI 10.1186/1756-9966-30-35↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhao‐Shen Li · 3 shared papers, 2013–2017 · strength 0.16
  2. Yunliang Sun · 2 shared papers, 2013–2019 · strength 0.16
  3. Xiaofeng Yu · 2 shared papers, 2013–2019 · strength 0.16
  4. Jun Gao · 4 shared papers, 2011–2016 · strength 0.15
  5. Jianxia Ma · 2 shared papers, 2011–2019 · strength 0.14
  6. Yan-fang Gong · 3 shared papers, 2011–2016 · strength 0.12
  7. Jiefang Guo · 2 shared papers, 2013–2017 · strength 0.12
  8. Jun Hao · 1 shared paper, 2017 · strength 0.08
  9. Xiaoyan Ning · 1 shared paper, 2016 · strength 0.05
  10. Qiwen Ben · 1 shared paper, 2016 · strength 0.05
  11. Yiqi Du · 1 shared paper, 2016 · strength 0.05
  12. Jianxia Ma · 1 shared paper, 2013 · strength 0.04
  13. Zhaoshen Li · 1 shared paper, 2013 · strength 0.04
  14. Shu-De Li · 1 shared paper, 2013 · strength 0.03
  15. Kaixuan Wang · 1 shared paper, 2013 · strength 0.03
  16. Jianming Zheng · 1 shared paper, 2013 · strength 0.03
  17. Zheng Lu · 1 shared paper, 2011 · strength 0.02
  18. Luo‐Wei Wang · 1 shared paper, 2011 · strength 0.02
  19. Yan Liu · 1 shared paper, 2011 · strength 0.02
  20. Zhendong Jin · 1 shared paper, 2011 · strength 0.02
  21. Zhaoshen Li · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.